ATE514431T1 - Allergie-vakzine-zusammensetzung, herstellungsverfahren dafür und ihre verwendung bei der behandlung von allergien - Google Patents

Allergie-vakzine-zusammensetzung, herstellungsverfahren dafür und ihre verwendung bei der behandlung von allergien

Info

Publication number
ATE514431T1
ATE514431T1 AT03724819T AT03724819T ATE514431T1 AT E514431 T1 ATE514431 T1 AT E514431T1 AT 03724819 T AT03724819 T AT 03724819T AT 03724819 T AT03724819 T AT 03724819T AT E514431 T1 ATE514431 T1 AT E514431T1
Authority
AT
Austria
Prior art keywords
allergies
treatment
production
vaccine composition
allergy vaccine
Prior art date
Application number
AT03724819T
Other languages
English (en)
Inventor
Gonzalez Miriam De San Juan Lastre
Martin Oliver German Perez
Rosado Alexis Labrada
Martinez Igor Bidot
Lastre Jorge Ernesto Perez
Granada Gustavo Rafael Bracho
Campo Alonso Judith Monica Del
Lastre Dainerys Aleida Perez
Ramos Elisa Facenda
Vignier Caridad Zayas
Martinez Claudio Rodriguez
Gonzalez Victoriano Gustavo Sierra
Original Assignee
Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros
Ct Nac Biopreparados
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros, Ct Nac Biopreparados filed Critical Inst Finlay Ct De Investigacion Produccion De Vacunas Y Sueros
Application granted granted Critical
Publication of ATE514431T1 publication Critical patent/ATE514431T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03724819T 2002-05-08 2003-05-08 Allergie-vakzine-zusammensetzung, herstellungsverfahren dafür und ihre verwendung bei der behandlung von allergien ATE514431T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20020091A CU22983A1 (es) 2002-05-08 2002-05-08 Composición vacunal contra las alergias y método para su obtención y empleo en el tratamiento de las mismas
PCT/CU2003/000007 WO2003094964A1 (es) 2002-05-08 2003-05-08 Composición vacunal contra las alergias, método para su obtención y empleo en el tratamiento de las mismas

Publications (1)

Publication Number Publication Date
ATE514431T1 true ATE514431T1 (de) 2011-07-15

Family

ID=34916998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724819T ATE514431T1 (de) 2002-05-08 2003-05-08 Allergie-vakzine-zusammensetzung, herstellungsverfahren dafür und ihre verwendung bei der behandlung von allergien

Country Status (15)

Country Link
US (1) US7648709B2 (de)
EP (1) EP1520587B1 (de)
KR (1) KR101058350B1 (de)
CN (1) CN100540052C (de)
AR (1) AR039982A1 (de)
AT (1) ATE514431T1 (de)
AU (1) AU2003229258A1 (de)
BR (1) BR0309901A (de)
CU (1) CU22983A1 (de)
DK (1) DK1520587T3 (de)
ES (1) ES2368731T3 (de)
MX (1) MXPA04011070A (de)
MY (1) MY146106A (de)
PT (1) PT1520587E (de)
WO (1) WO2003094964A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23420A1 (es) * 2003-12-30 2009-09-08 Univ De Cambridge Proteoliposomas y sus derivados como adyuvantes inductores de respuesta citotóxica y las formulaciones resultantes
EP1872792A1 (de) * 2006-06-29 2008-01-02 Biotech Tools S.A. Methode zur Herstellung eines hydrolysierten Allergens
ZA200900899B (en) * 2006-08-07 2010-07-28 Harvard College Protein matrix vaccines and methods of making and administering such vaccines
EP2042193A1 (de) * 2007-09-28 2009-04-01 Biomay AG RNA-Impfstoffe
WO2009083589A1 (en) * 2008-01-02 2009-07-09 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
CU20080215A7 (es) 2008-11-19 2012-06-21 Inst Finlay Vacunas unitemporales
KR101413844B1 (ko) 2008-12-09 2014-06-30 화이자 백신스 엘엘씨 ＩｇＥ ＣＨ３ 펩티드 백신
CU20100083A7 (es) 2010-05-05 2012-06-21 Inst Finlay Tolerogenos adyuvados como vacuna de malaria
CN101972472A (zh) * 2010-10-26 2011-02-16 北京新华联协和药业有限责任公司 一种变应原疫苗纯化及其制备的方法
CU20110202A7 (es) 2011-11-02 2013-12-27 Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
EP2689775A1 (de) 2012-07-25 2014-01-29 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Cochlea mit nur einem mikrobenassoziierten Molekularmuster (MAMP)
WO2019242662A1 (zh) * 2018-06-22 2019-12-26 江苏众红生物工程创药研究院有限公司 重组尘螨变应原蛋白药物合剂及其应用
CN113546165A (zh) * 2020-04-26 2021-10-26 微缔医药科技(杭州)有限公司 一种螨变应原脂质体干粉吸入剂及其制备方法
CN112023062A (zh) * 2020-09-18 2020-12-04 北京基因安科技有限公司 一个用可溶性IgE受体抑制过敏反应的方法
IT202200011459A1 (it) * 2022-05-31 2023-12-01 Anallergo S P A Uso della ultrafiltrazione per la produzione di estratti allergenici purificati

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695694A (en) 1986-02-14 1987-09-22 Fusion Systems Corporation Structure for minimizing microwave leakage
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
US5834015A (en) * 1996-09-11 1998-11-10 Albany Medical College Protein-lipid vesicles and autogenous vaccine comprising the same
IT1318691B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche del gruppo 2 di dermatophagoides.
DE60238471D1 (de) * 2001-03-09 2011-01-13 Id Biomedical Corp Quebec Proteosom-liposaccharid-vakzine-adjuvans

Also Published As

Publication number Publication date
AU2003229258A8 (en) 2003-11-11
EP1520587B1 (de) 2011-06-29
CN100540052C (zh) 2009-09-16
AR039982A1 (es) 2005-03-09
KR101058350B1 (ko) 2011-08-22
US7648709B2 (en) 2010-01-19
EP1520587A1 (de) 2005-04-06
MY146106A (en) 2012-06-29
DK1520587T3 (da) 2011-10-17
CN1658900A (zh) 2005-08-24
AU2003229258A1 (en) 2003-11-11
CU22983A1 (es) 2004-09-09
PT1520587E (pt) 2011-09-27
MXPA04011070A (es) 2005-07-14
BR0309901A (pt) 2008-08-12
WO2003094964A1 (es) 2003-11-20
US20060110435A1 (en) 2006-05-25
KR20050025175A (ko) 2005-03-11
ES2368731T3 (es) 2011-11-21

Similar Documents

Publication Publication Date Title
ATE448206T1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
ATE389649T1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
DE50306850D1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
DE50214540D1 (de) Stanz bei der behandlung von wunden
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE60112791D1 (de) Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität
DE60209486D1 (de) Pyranoindazole und ihre verwendung in der glaukombehandlung
ATE537155T1 (de) Zur behandlung von diabetes, obesitas und dyslipidämie geeignete inhibitoren von 11-beta- hydroxysteroid-dehydrogenase-1
ATE514431T1 (de) Allergie-vakzine-zusammensetzung, herstellungsverfahren dafür und ihre verwendung bei der behandlung von allergien
DE60319810D1 (de) Anschwemmfiltermedien und herstellungs- und verwendungsverfahren
ATE479437T1 (de) Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
EP1603391A4 (de) Verfahren zur verwendung von zusammensetzungen, umfassend hitzeschockproteine oder alpha-2-macroglobulin bei der behandlung von krebs und infektionskrankheiten
ATE420866T1 (de) 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
DE602004015269D1 (de) Piperazin derivate und ihre verwendung für die behandlung von neurologischen und psychiatrischen krankheiten.
IS7699A (is) Afleiður af díoxan-2-alkýl karbamötum, framleiðslu aðferð þeirra og notkun við meðferð sjúkdóma
EP1499186A4 (de) Verwendung von häm-oxygenase-1 und häm-abbauprodukte
DE60325967D1 (de) Stimulierung von hämatopoiese bei ex vivo aktivierten immunzellen
ATE517893T1 (de) Arylvinylazacycloalkan-verbindungen sowie herstellungsverfahren dafür und verwendung davon
ATE303379T1 (de) 4-(phenyl-piperidin-4-ylidenmethyl)-benzamid- derivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
DE60230162D1 (de) Polymerisate und ihre verwendung
DE60317693D1 (de) Methode und verwendung von thermostabilen rna-ligasen
DE60311254D1 (de) Fluor enthaltende wasserlösliche nichtionische tenside, verwendung davon und herstellungsverfahren dafür
DE60324697D1 (de) Flüssigkeitsausstossvorrichtung und herstellungsverfahren dafür
ATE362923T1 (de) 4-(phenylpiperazinylmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen oder gastrointestinalen erkrankungen
EE200300527A (et) 4-(fenüülpiperidiin-4-ülideenmetüül)bensamiidi derivaadid ja nende kasutamine valu, ärevuse või seedetrakti häirete raviks

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1520587

Country of ref document: EP